These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11499722)

  • 1. Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis.
    Wyse DG; Talajic M; Hafley GE; Buxton AE; Mitchell LB; Kus TK; Packer DL; Kou WH; Lemery R; Santucci P; Grimes D; Hickey K; Stevens C; Singh SN
    J Am Coll Cardiol; 2001 Aug; 38(2):344-51. PubMed ID: 11499722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Fisher JD; Buxton AE; Lee KL; Packer DL; Echt DS; Denes P; Lehmann MH; DiMarco JP; Roy D; Hafley GE;
    Am J Cardiol; 2007 Jul; 100(1):76-83. PubMed ID: 17599445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications.
    Pires LA; Lehmann MH; Buxton AE; Hafley GE; Lee KL;
    J Am Coll Cardiol; 2001 Oct; 38(4):1156-62. PubMed ID: 11583897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MUSTT study: evaluating testing and treatment.
    Klein HU; Reek S
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():45-50. PubMed ID: 10590488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and therapy for patients with nonsustained ventricular tachycardia.
    Prystowsky EN
    Am J Cardiol; 2000 Nov; 86(9A):34K-39K. PubMed ID: 11084098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
    Mewis C; Kühlkamp V; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jun; 33(7):1989-95. PubMed ID: 10362204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of nonsustained ventricular tachycardia after revascularization.
    Mittal S; Lomnitz DJ; Mirchandani S; Stein KM; Markowitz SM; Slotwiner DJ; Iwai S; Das MK; Lerman BB
    J Cardiovasc Electrophysiol; 2002 Apr; 13(4):342-6. PubMed ID: 12033350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
    van Hemel NM; Kingma JH; Defauw JJ; Hoogteijling-van Dusseldorp E; Kelder JC; Beukema WP; Vermeulen FE
    Eur Heart J; 1996 Apr; 17(4):564-73. PubMed ID: 8733090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Ellison KE; Hafley GE; Hickey K; Kellen J; Coromilas J; Stein KM; Lee KL; Buxton AE;
    Circulation; 2002 Nov; 106(21):2694-9. PubMed ID: 12438295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.
    Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE;
    Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of end points of serial drug testing in patients with sustained ventricular tachycardia after healing of acute myocardial infarction.
    Wasilewski SJ; Ferrick KJ; Roth JA; Kim SG; Fisher JD
    Am J Cardiol; 1995 Dec; 76(17):1247-52. PubMed ID: 7503005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Piccini JP; Hafley GE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Buxton AE;
    J Cardiovasc Electrophysiol; 2009 Aug; 20(8):850-5. PubMed ID: 19490266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks.
    Russo AM; Hafley GE; Lee KL; Stamato NJ; Lehmann MH; Page RL; Kus T; Buxton AE;
    Circulation; 2003 Jul; 108(1):67-72. PubMed ID: 12821551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial.
    Russo AM; Stamato NJ; Lehmann MH; Hafley GE; Lee KL; Pieper K; Buxton AE;
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):993-8. PubMed ID: 15363069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.